Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
3,071 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00539331 | Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients | terminated | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jun 1, 2011 | clinicaltrials |
| NCT01360892 | Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography(PICTURE) | unknown | — | 1,000 | Kindai UniversityOTHER | 1 | May 26, 2011 |
| NCT00704366 | AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours | completed | Phase 1 | 18 | AstraZenecaINDUSTRY | 1 | May 16, 2011 | clinicaltrials |
| NCT00337454 | Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan | completed | Phase 1 / Phase 2 | 48 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 14, 2011 | clinicaltrials |
| NCT01082510 | Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study) | unknown | Phase 3 | 288 | Urological Oncology Council of Northern TokyoOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00732992 | A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies | completed | Phase 1 | 12 | PfizerINDUSTRY | 1 | Mar 17, 2011 | clinicaltrials |
| NCT00631410 | Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer | completed | Phase 1 | 12 | PfizerINDUSTRY | 1 | Mar 16, 2011 | clinicaltrials |
| NCT00937664 | Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine | terminated | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00252759 | Iressa Case Control Study in Japan | completed | — | 6,000 | AstraZenecaINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00479076 | A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients | completed | Phase 1 | 22 | SanofiINDUSTRY | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00390936 | A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 13 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00644488 | A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer | completed | Phase 1 | 7 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT01018745 | Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan | completed | Phase 1 | 3 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 7, 2011 | clinicaltrials |
| NCT00822991 | Sonazoid Enhanced Liver Cancer Trial for Early Detection | unknown | N/A | 760 | Kindai UniversityOTHER | 1 | Dec 30, 2010 | clinicaltrials |
| NCT01267578 | Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) | unknown | Phase 2 | 60 | University of YamanashiOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT01266707 | Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma | unknown | Phase 1 | 9 | Fukushima Medical UniversityOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01266720 | HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) | unknown | Phase 1 | 6 | Fukushima Medical UniversityOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT00482703 | A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia | completed | Phase 1 / Phase 2 | 23 | Bristol-Myers SquibbINDUSTRY | 1 | Dec 17, 2010 | clinicaltrials |
| NCT00339144 | Study of Dasatinib (BMS-354825) in Patients With Solid Tumors | completed | Phase 1 | 16 | Bristol-Myers SquibbINDUSTRY | 1 | Dec 15, 2010 | clinicaltrials |
| NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy(SILIUS) | completed | Phase 1 / Phase 2 | 37 | Kindai UniversityOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00328120 | Faslodex 500mg Multiple Dose Tolerability Study in BC Patients | completed | Phase 1 | 20 | AstraZenecaINDUSTRY | 1 | Nov 17, 2010 | clinicaltrials |
| NCT00106158 | Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1 | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Nov 5, 2010 | clinicaltrials |
| NCT00635336 | Novel Peptide Vaccination for Patients With Advanced Bladder Cancer | completed | Phase 1 | 20 | Iwate Medical UniversityOTHER | 1 | Oct 21, 2010 | clinicaltrials |
| NCT00669292 | PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer | unknown | Phase 1 / Phase 2 | 29 | Wakayama Medical UniversityOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | unknown | Phase 1 / Phase 2 | 32 | Wakayama Medical UniversityOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00515450 | Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis | completed | Phase 3 | 46 | Benesis CorporationINDUSTRY | 1 | Jul 30, 2010 | clinicaltrials |
| NCT01170845 | Effect of Neutrophil Elastase Inhibitor on Lung Injury After Esophagectomy(NEIE) | completed | N/A | 31 | Yokohama City University Medical CenterOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00612183 | Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma | completed | Phase 2 | 56 | SymBio PharmaceuticalsINDUSTRY | 1 | Jul 22, 2010 | clinicaltrials |
| NCT00412789 | Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan | completed | Phase 1 | 15 | Novartis PharmaceuticalsINDUSTRY | 1 | May 31, 2010 | clinicaltrials |
| NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00209729 | Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. | suspended | Phase 1 / Phase 2 | 50 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00209742 | Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer | unknown | Phase 3 | 340 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00723216 | Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery | completed | Phase 3 | 151 | SanofiINDUSTRY | 1 | Apr 5, 2010 | clinicaltrials |
| NCT00191269 | Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen | completed | Phase 2 | 68 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 17, 2010 | clinicaltrials |
| NCT00334802 | Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00254540 | Study of SU011248 in Patients With Advanced Kidney Cancer | completed | Phase 2 | 51 | PfizerINDUSTRY | 1 | Feb 23, 2010 | clinicaltrials |
| NCT01000896 | Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel | withdrawn | Phase 1 | 27 | AstraZenecaINDUSTRY | 1 | Feb 4, 2010 | clinicaltrials |
| NCT00232661 | PROACT - Pre-Operative Arimidex Compared To Tamoxifen | completed | Phase 3 | 452 | AstraZenecaINDUSTRY | 10 | Feb 3, 2010 | clinicaltrials |
| NCT00280410 | Study Investigating the Effect of E7337 on Tumor Like Lesions in Computed Tomography (CT) of the Liver | completed | Phase 2 / Phase 3 | 192 | Eisai Inc.INDUSTRY | 1 | Jan 29, 2010 | clinicaltrials |
| NCT00915863 | Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy | unknown | N/A | 150 | Wakayama Medical UniversityOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00628186 | Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy | completed | N/A | 100 | Wakayama Medical UniversityOTHER | 1 | Jan 18, 2010 | clinicaltrials |
| NCT00677287 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677326 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 1 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677612 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00678509 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00303524 | Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients | completed | Phase 2 | 170 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00191191 | To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 226 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00380588 | Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials